• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对巨核细胞进行编程以产生工程化血小板来递送非天然蛋白质。

Programming megakaryocytes to produce engineered platelets for delivering non-native proteins.

作者信息

Islam Farhana, Javdan Shwan B, Lewis Mitchell R, Craig James D, Wu Han, Deans Tara L

机构信息

Department of Biomedical Engineering, University of Utah, Salt Lake City, UT 84112, USA.

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.

出版信息

bioRxiv. 2025 Jan 27:2023.10.13.562311. doi: 10.1101/2023.10.13.562311.

DOI:10.1101/2023.10.13.562311
PMID:37873465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10592833/
Abstract

Platelets are anucleate cells naturally filled with secretory granules that store large amounts of protein to be released in response to certain physiological conditions. Cell engineering can endow platelets with the ability to deliver non-native proteins by modifying them as they develop during the cell fate process. This study presents a strategy to efficiently generate mouse platelets from pluripotent stem cells and demonstrates their potential as bioengineered protein delivery platforms. By modifying megakaryocytes, the progenitor cells of platelets, we successfully engineered platelets capable of packaging and delivering non-native proteins. These engineered platelets can offer flexible delivery platforms to release non-native proteins in a controlled manner upon activation when packaged into α-granules or deliver active enzymes to genetically alter recipient cells. Our findings highlight platelets as a promising tool for protein delivery in cell therapy applications.

摘要

血小板是无核细胞,天然充满分泌颗粒,这些颗粒储存大量蛋白质,可在特定生理条件下释放。细胞工程可以通过在细胞命运过程中对血小板进行修饰,赋予其递送非天然蛋白质的能力。本研究提出了一种从多能干细胞高效生成小鼠血小板的策略,并证明了它们作为生物工程蛋白质递送平台的潜力。通过修饰血小板的祖细胞巨核细胞,我们成功构建了能够包装和递送非天然蛋白质的血小板。这些工程化血小板可以提供灵活的递送平台,当包装到α颗粒中时,在激活后以可控方式释放非天然蛋白质,或者递送活性酶以基因改造受体细胞。我们的研究结果突出了血小板作为细胞治疗应用中蛋白质递送的一种有前景的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/813a86b49a7c/nihpp-2023.10.13.562311v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/9e107701d358/nihpp-2023.10.13.562311v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/ced5eb263f6a/nihpp-2023.10.13.562311v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/9829332d6505/nihpp-2023.10.13.562311v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/813a86b49a7c/nihpp-2023.10.13.562311v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/9e107701d358/nihpp-2023.10.13.562311v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/ced5eb263f6a/nihpp-2023.10.13.562311v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/9829332d6505/nihpp-2023.10.13.562311v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6eb/11781426/813a86b49a7c/nihpp-2023.10.13.562311v2-f0004.jpg

相似文献

1
Programming megakaryocytes to produce engineered platelets for delivering non-native proteins.对巨核细胞进行编程以产生工程化血小板来递送非天然蛋白质。
bioRxiv. 2025 Jan 27:2023.10.13.562311. doi: 10.1101/2023.10.13.562311.
2
Programming megakaryocytes to produce engineered platelets for delivering non-native proteins.对巨核细胞进行编程以生产用于递送非天然蛋白质的工程血小板。
Commun Biol. 2025 Apr 19;8(1):638. doi: 10.1038/s42003-025-08017-8.
3
Targeting transgenic proteins to alpha granules for platelet-directed gene therapy.将转基因蛋白靶向定位于α颗粒用于血小板导向的基因治疗。
Mol Ther Nucleic Acids. 2022 Jan 3;27:774-786. doi: 10.1016/j.omtn.2021.12.038. eCollection 2022 Mar 8.
4
Packaging of supplemented urokinase into alpha granules of in vitro-grown megakaryocytes for targeted nascent clot lysis.将尿激酶原包装到体外生长的巨核细胞的α颗粒中,用于靶向新生血栓的溶解。
Blood Adv. 2024 Jul 23;8(14):3798-3809. doi: 10.1182/bloodadvances.2024012835.
5
Targeting cargo to an unconventional secretory system within megakaryocytes allows the release of transgenic proteins from platelets.将 cargo 靶向到巨核细胞内的非常规分泌系统可使转基因蛋白从血小板中释放。
J Thromb Haemost. 2024 Nov;22(11):3235-3248. doi: 10.1016/j.jtha.2024.07.021. Epub 2024 Aug 8.
6
Packaging of supplemented urokinase into naked alpha-granules of -grown megakaryocytes for targeted therapeutic delivery.将补充的尿激酶包装到生长的巨核细胞的裸α颗粒中用于靶向治疗递送。
bioRxiv. 2023 Dec 5:2023.12.05.570278. doi: 10.1101/2023.12.05.570278.
7
Megakaryocytes package contents into separate α-granules that are differentially distributed in platelets.巨核细胞将内容物包装到单独的α-颗粒中,这些颗粒在血小板中呈差异分布。
Blood Adv. 2019 Oct 22;3(20):3092-3098. doi: 10.1182/bloodadvances.2018020834.
8
Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications.用于疾病建模和未来临床应用的诱导多能干细胞衍生的巨核细胞和血小板
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2007-2013. doi: 10.1161/ATVBAHA.117.309197. Epub 2017 Oct 5.
9
Genetic engineering of megakaryocytes from blood progenitor cells using messenger RNA lipid nanoparticles.利用信使核糖核酸脂质纳米颗粒对血液祖细胞来源的巨核细胞进行基因工程改造。
J Thromb Haemost. 2025 Jan;23(1):306-313. doi: 10.1016/j.jtha.2024.09.008. Epub 2024 Sep 26.
10
Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome.血小板是 Hurler 综合征小鼠溶酶体酶储存、分布和递送的有效且具有保护作用的储存库。
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2680-5. doi: 10.1073/pnas.1323155111. Epub 2014 Feb 3.

本文引用的文献

1
Targeting cargo to an unconventional secretory system within megakaryocytes allows the release of transgenic proteins from platelets.将 cargo 靶向到巨核细胞内的非常规分泌系统可使转基因蛋白从血小板中释放。
J Thromb Haemost. 2024 Nov;22(11):3235-3248. doi: 10.1016/j.jtha.2024.07.021. Epub 2024 Aug 8.
2
Nucleosome remodeler exclusion by histone deacetylation enforces heterochromatic silencing and epigenetic inheritance.组蛋白去乙酰化排斥核小体重塑因子,从而加强异染色质沉默和表观遗传遗传。
Mol Cell. 2024 Sep 5;84(17):3175-3191.e8. doi: 10.1016/j.molcel.2024.07.006. Epub 2024 Aug 2.
3
Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle.
适应体外培养会降低人造血干细胞的活性,而与细胞周期无关。
Blood. 2024 Aug 15;144(7):729-741. doi: 10.1182/blood.2023021426.
4
Advancing in vivo reprogramming with synthetic biology.用合成生物学推进体内重编程。
Curr Opin Biotechnol. 2024 Jun;87:103109. doi: 10.1016/j.copbio.2024.103109. Epub 2024 Mar 24.
5
In Vitro Generation of Megakaryocytes from Engineered Mouse Embryonic Stem Cells.从工程化的小鼠胚胎干细胞体外生成巨核细胞。
Methods Mol Biol. 2024;2774:279-301. doi: 10.1007/978-1-0716-3718-0_19.
6
Mass production of iPSC-derived platelets toward the clinical application.诱导多能干细胞衍生血小板的大规模生产迈向临床应用。
Regen Ther. 2024 Jan 4;25:213-219. doi: 10.1016/j.reth.2023.12.009. eCollection 2024 Mar.
7
Probiotic-guided CAR-T cells for solid tumor targeting.益生菌引导的 CAR-T 细胞用于实体瘤靶向治疗。
Science. 2023 Oct 13;382(6667):211-218. doi: 10.1126/science.add7034. Epub 2023 Oct 12.
8
Development of an efficient, ready to use, blood platelet-release device based on two new flow regime parameters: The periodic hydrodynamic loading and the shear stress accumulation.基于两种新的流态参数:周期性流体动力加载和剪切应力积累,开发一种高效、即用型的血小板释放装置。
N Biotechnol. 2023 Nov 25;77:68-79. doi: 10.1016/j.nbt.2023.07.002. Epub 2023 Jul 11.
9
In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation.体外人造血干/祖细胞扩增与分化。
Cells. 2023 Mar 14;12(6):896. doi: 10.3390/cells12060896.
10
The sound of silence: Transgene silencing in mammalian cell engineering.沉默的声音:哺乳动物细胞工程中的转基因沉默。
Cell Syst. 2022 Dec 21;13(12):950-973. doi: 10.1016/j.cels.2022.11.005.